Conference Coverage

In utero COVID exposure tied to developmental differences in infants


 

FROM EPA 2022

More research needed

Commenting on the findings, Livio Provenzi, PhD, a psychologist and researcher in developmental psychobiology at the University of Pavia (Italy), noted there is a “great need” to study the direct and indirect effect of the COVID-19 pandemic on parents and their children. “Pregnancy is a period of life which shapes much of our subsequent development, and exposure to adversity in pregnancy can leave long-lasting biological footprints.”

Dr. Provenzi, who was not involved in the study, added in the release that the findings reinforce “evidence of epigenetic alterations in infants born from mothers exposed to pandemic-related stress during pregnancy.

“It shows we need more large-scale, international research to allow us to understand the developmental effects of this health emergency and to deliver better quality of care to parents and infants.”

The study was funded by the Spanish Ministry of Economy and Competitiveness, Instituto de Salud Carlos III through the University of Barcelona multicenter project and the Government of Cantabria. No relevant financial relationships were declared.

A version of this article first appeared on Medscape.com.

Pages

Recommended Reading

FDA authorizes Pfizer’s COVID booster for kids ages 5 to 11
Federal Practitioner
Omicron breakthrough cases boost protection, studies say
Federal Practitioner
Pancreatic involvement in COVID-19: What do we know?
Federal Practitioner
CDC signs off on COVID boosters in children ages 5-11
Federal Practitioner
Does COVID-19 raise the risk for diabetes?
Federal Practitioner
Anxiety in America: COVID ‘takes a backseat’ to global events
Federal Practitioner
How to manage drug interactions with Paxlovid for COVID-19
Federal Practitioner
Researchers find a pathway to prevent COVID infection
Federal Practitioner
MS and COVID-19: Conflicting signs on risk but some trends are clearer
Federal Practitioner
Immunosuppressed rheumatic patients not at high risk of breakthrough COVID-19
Federal Practitioner